XBIO: Xenetic Biosciences, Inc. Stock

by  •  • Comments Off on XBIO: Xenetic Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.93
Enterprise Value ($M) -3.05
Book Value ($M) 9.80
Book Value / Share 6.36
Price / Book 0.61
NCAV ($M) 8.78
NCAV / Share 5.70
Price / NCAV 0.68

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.32

Liquidity (mrq)
Quick Ratio 11.84
Current Ratio 11.84

Balance Sheet (mrq) ($M)
Current Assets 9.59
Assets 10.61
Liabilities 0.81
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.54
Operating Income -4.52
Net Income -4.13
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.11
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-18 13D/A CLS Therapeutics, LLC 14.00 8.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-06 923 10,557 8.74
2024-05-03 615 5,746 10.70
2024-05-02 129 3 4,300.00
2024-05-01 223 309 72.17

(click for more detail)

Similar Companies
VXRT – Vaxart, Inc. VYNE – VYNE Therapeutics Inc.
WINT – Windtree Therapeutics, Inc. XCUR – Exicure, Inc.
XFOR – X4 Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io